Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Email: nm@mva.org
    Phone: (M) +45 6141 8634 Linkedin

    Third annual meeting in the Danish Biobank Network

    With Aarhus Universitety Hospital as host, we are happy to invite you all to the next meeting in the Danish Biobank Network. As always, everybody is welcome, and the event is free of charge. At the session at 14:20 there is a chance to in 5 min present new initiatives, resources, collaborations etc. Just send an e-mail to labo@ssi.dk, so we know how many that wants to speak.

    Date: January 18th, 2018
    Time: 10:00–15:00
    Venue: Aarhus University Hospital, Brendstrupgårdsvej 21A, 8200 Aarhus N
    FREE: For members of Medicon Valley Alliance

    READ MORE & SIGN UP

    Program

    10:00

    Welcome by Lasse Boding, Coordinator, Danish National Biobank

    10:10

    National guidelines for public-private partnerships (PPP) by Lasse Boding, Coordinator, Danish National Biobank

    10:20

    Evaluation of suppliers– Novo Nordisk’s approach to responsible sourcing of human biosamples by Brian Clark, Senior Director, Novo Nordisk

    10:40

    Healthcare Denmark, Danish health and PPP in an international context by Hans Erik Henriksen, CEO, Healthcare Denmark

    11:00

    Pre-competitive collaboration between biobanks and industry by Christian Jonasson, Senior Researcher, Norwegian University of Science and Technology

    11:20

    Medicon Valley Alliance – the Danish-Swedish life science hub for PPP by Petter Hartman, CEO, Medicon Valley Alliance

    11:40

    Discussion

    12:00

    Lunch

    13:00

    GWAS in the Danish Blood Donor Study – an example of a large-scale PPP by Christian Erikstrup, Professor, Aarhus University Hospital

    13:20

    Three local cases from the Department of Molecular Medicine (MOMA) at Aarhus University Hospital:

    • Prostate cancer biomarker development by Siri Strand, Postdoc, Prostate Cancer Research Group

    • Circulating tumor DNA as a marker for monitoring residual disease after colon cancer surgery by Claus Lindbjerg Andersen, Professor, Colorectal Cancer Research Group

    • Blood and urine samples for monitoring aggressiveness, disease relapse and treatment response in bladder cancer by Lars Dyrskjøt Andersen, Professor, Bladder Cancer Research Group

    14:20

    5 min biobank updates on new resources, initiatives and facilities

    15:00

    Closing remarks

     ARRANGED BY